Nanjing Zenshine Pharmaceuticals

Quick facts

Phase 3 pipeline

• ZX-7101A for oral suspension · Oncology
  ZX-7101A is a small molecule that targets the HIF-1α pathway.

Phase 1 pipeline

• ZX-4081
• ZX-7101A and Oseltamivir
• ZX-7101A dry suspension
• ZX-8177

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Nanjing Zenshine Pharmaceuticals portfolio CI brief
• Nanjing Zenshine Pharmaceuticals pipeline updates RSS